The Trojan Horse: How Vaccines Deliver Aluminum to Infant Brains

An Essay

Preface

This essay relies heavily on the groundbreaking research of Dr Christopher Exley, who spent forty years at Keele University studying aluminum toxicity and became the world's foremost authority on the subject. His recent publications documenting aluminum deposits in autistic brain tissue, combined with his decades of peer-reviewed research, form the scientific foundation of this work.

I have also drawn extensively from the analytical frameworks of J.B. Handley and Toby Rogers, who have masterfully connected disparate scientific discoveries to reveal the mechanism by which aluminum adjuvants in vaccines trigger autism. The work of Dr. Guillemette Crépeaux and her French colleagues on aluminum transport mechanisms, and the epidemiological studies of independent researchers like Mawson, Hooker, and Miller, provide crucial supporting evidence.

These scientists have risked their careers, faced institutional suppression, and endured professional exile to bring this truth to light. Dr. Exley was forced from his university position after his autism findings. Dr. Crépeaux struggles for funding while studying one of the most important medical questions of our time. Yet they persist, because the science demands it and children's lives depend on it.

I am merely a compiler and translator of their work, attempting to make their discoveries accessible to those who need to understand what has been done to a generation of children. All errors in interpretation or presentation are my own.

—Unbekoming

1. The Aluminum Paradox

Aluminum is the third most abundant element in the Earth's crust, yet it does not exist naturally in living biological systems. Nature, across billions of years of evolution, developed elaborate mechanisms to keep this element out of living tissue. Silicon-rich compounds in soil bind aluminum and prevent its uptake by plants. Cell membranes evolved specific barriers against it. The human gut, when functioning properly, blocks the vast majority of ingested aluminum from entering the bloodstream.

This fundamental biological exclusion should have been warning enough. Instead, we inject it directly into our infants.

Dr. Christopher Exley spent nearly forty years studying this paradox at Keele University, becoming the world's leading authority on aluminum toxicity. His recent Substack posts reveal something extraordinary: direct visual evidence of aluminum deposits in the brains of young people who died with autism diagnoses. In a 15-year-old boy, Exley's team measured aluminum levels of 8.74 (11.59) μg/g dry weight in the occipital lobe—among the highest values for aluminum in human brain tissue yet recorded, as Exley asks: "one has to question why?"

The images are damning. Orange and yellow fluorescence marks aluminum's presence, concentrated not randomly throughout the tissue but specifically within immune cells. Microglia and macrophages, the brain's housekeeping cells, appear loaded with aluminum they cannot digest or eliminate. In one striking image from the hippocampus—the brain region targeted in epilepsy—glial cells loaded with aluminum, likely microglia, surround an area of aluminum-induced damage, possibly neuronal damage.

The hippocampus finding connects two observations that parents have long reported but medicine has dismissed: that autism and seizures often appear together, and that both frequently emerge after vaccination. Exley's images suggest why. The hippocampus, critical for memory and emotional regulation, sits at the intersection of autism and epilepsy pathology. When aluminum-loaded immune cells breach the blood-brain barrier and deposit their cargo there, they trigger what Dr. Paul Patterson would later call "an ongoing, permanent immune-system activation in the brains of autistic people."

This isn't theoretical. In brain tissue from a 50-year-old man with autism, Exley found proliferation of positive aluminum fluorescence across entire tissue sections. The meninges—the protective membranes surrounding the brain—showed multiple inflammatory cells, probably lymphocytes and macrophages, loaded with aluminum. These weren't healing; they were in a state of chronic activation, permanently switched on by the presence of a metal the body has no mechanism to eliminate.

Exley draws a straight line from his findings to the Camelford water poisoning incident of 1988, where 20,000 people were exposed to aluminum-contaminated drinking water. Mrs. Carole Cross, who died from congophilic amyloid angiopathy (CAA), a form of Alzheimer's disease rarely if ever observed in someone in their fifties, showed the same pattern: aluminum predominantly inside inflammatory and glial cells including microglia, astrocytes, lymphocytes, and cells lining the choroid plexus. In 2013, at the inquest into her death, coroner Michael Rose confirmed in his narrative verdict a role for aluminum in the brain damage leading to her death—the first time in a court of law where human exposure to aluminum was causatively linked to Alzheimer's disease.

The parallel is unsettling. In both CAA (the case of Mrs Cross) and autism, as Exley states, "an acute exposure to aluminum (in drinking water and vaccines respectively) lead to excessive accumulation of aluminum in brain tissue resulting in severe inflammation and almost identical aluminum-driven brain tissue pathology."

The mechanism matters as much as the outcome, and Exley identified that too. When his team investigated whether amyloid beta protein was present in autism brain tissue, they confirmed not only its presence but that, as in CAA, the amyloid beta was predominantly associated with the vasculature—essentially unequivocal evidence of CAA in autism brain tissue.

This is what autism is—not a genetic mystery or an unexplained epidemic, but as it's more correctly called, vaccine-induced encephalitis, brain inflammation caused by aluminum that shouldn't be there, carried by immune cells doing what they evolved to do, triggered by injections that bypass every protective mechanism nature developed.

Exley's conclusion is unequivocal: "Ever since we first measured and imaged aluminum in brain tissue in autism I have racked my brain to find any reason why such a load of aluminum and in particular intracellular non-neuronal aluminum would not have a causal role in the brain damage occurring in autism. I failed." After decades of research, publishing over 200 peer-reviewed papers on aluminum toxicity, he states simply: "Aluminum has a causal role in the instigation and subsequent development of autism."

2. The Trojan Horse Mechanism

The story of how aluminum reaches the brain reads like a Greek tragedy—our own immune system, designed to protect us, becomes the unwitting accomplice in our destruction. J.B. Handley, whose son regressed into autism after routine vaccinations, spent years piecing together the biological mechanism that mainstream medicine refused to acknowledge. What he found was eleven separate discoveries, published since 2004 across different disciplines, that together reveal exactly how vaccines trigger autism.

The first piece fell into place in 2004 when Dr. Carlos Pardo-Villamizar at Johns Hopkins discovered that autistic brains are permanently inflamed. Not temporarily, not occasionally, but permanently. The brain's immune system remains activated in a subclinical state, fighting an enemy it cannot defeat. Dr. Paul Patterson at Caltech, reading Pardo-Villamizar's work, recognized the implications immediately: "There's an ongoing, permanent immune-system activation in the brains of autistic people. It's a subclinical state, because there's no overt infection. But it's there."

Patterson's own research revealed the second piece: immune activation events during critical periods of brain development cause autism. As he explained in 2006: "As we learn more about the connections between the brain and the immune system, we find that these seemingly independent networks of cells are, in fact, continually talking to each other." His team could reproduce autism-like behaviors in mice through maternal immune activation during pregnancy. The offspring displayed "deficient social and communicative behavior, as well as high levels of repetitive behaviors, all of which are hallmarks of autism."

When researchers at UC Davis replicated his work in monkeys, the results were identical: "MIA yields offspring with abnormal repetitive behaviors, communication, and social interactions. These results extended the findings in rodent MIA models to more human-like behaviors resembling those in both autism and schizophrenia."

But what triggers this immune activation after birth? This question haunted researchers until Christopher Shaw at the University of British Columbia conducted what seems, in retrospect, an obvious experiment. As he recounts: "We did the really simple experiment of taking the same stuff out of the vaccines, the aluminum hydroxide, and injecting it into mice, into the muscles, to see what would happen if we tried to mimic the vaccine schedule."

Shaw was "quite surprised to see how rapidly the behavioral symptoms emerged. They showed not only behavioral deficits of motor function but they ultimately showed cognitive deficits as well. Once we sacrificed the animals and started looking inside their brains and spinal cords, we found massive damage to motor neurons."

Then came the crucial discovery from French scientists Drs. Romain Gherardi and Josette Cadusseau in 2013. Their study, "Slow CCL2-Dependent Translocation of Biopersistent Particles from Muscle to Brain," demonstrated that aluminum adjuvant, when injected into the body of a mouse, ended up in the brain one year later. The study authors expressed serious concerns: "continuously escalating doses of this poorly biodegradable adjuvant in the population may become insidiously unsafe, especially in the case of overimmunization or immature/altered blood brain barrier."

"Insidiously unsafe" should cause any parent worry. The very thing they express concern about—escalating doses—is exactly what has been happening to children since the early 1990s, when the immunization schedule more than tripled.

The French team discovered the mechanism they called the "Trojan horse." As they explained: "Thus alum and other poorly biodegradable materials taken up at the periphery by phagocytes circulate in the lymphatic and blood circulation and can enter the brain using a Trojan horse mechanism similar to that used by infectious particles."

Like Greek soldiers hidden inside a wooden horse, aluminum particles hide inside macrophages that the brain welcomes as its own defenders. Once inside, the aluminum triggers exactly what it was designed to trigger in the muscle: immune activation. But in the brain, this activation doesn't resolve. The brain's immune cells, finding aluminum they cannot eliminate, remain permanently activated, creating the chronic neuroinflammation that defines autism.

In 2015, the same French team showed that aluminum adjuvant slowly makes its way to the brain, where it then stays, possibly forever, due to its "biopersistence"—our body has no ability to rid itself of aluminum adjuvant, because it's a man-made substance we have no natural designs to eliminate.

The mechanism explains a paradox that puzzled researchers: why do smaller, repeated doses of aluminum cause more damage than a single large dose? A 2016 French study, "Non-linear Dose-Response of Aluminium Hydroxide Adjuvant Particles: Selective Low Dose Neurotoxicity," found that the lowest dosage (200 mcg/Kg) was the most toxic. The high dosages caused intense inflammation at the injection site, forming "granulomas" that trapped the aluminum. But the 200 mcg/Kg dosage did not produce granulomas, allowing the aluminum to disperse throughout the body.

This is why the vaccine schedule matters so profoundly. A newborn receives the hepatitis B vaccine containing 250 micrograms of aluminum on their first day of life. By eighteen months, a fully vaccinated child has received 4,925 micrograms of injected aluminum—a near quadrupling from the 1,250 micrograms children received in the mid-1980s.

Chinese scientists in 2016 demonstrated the final piece of the puzzle. They injected newborn rats with the hepatitis B vaccine and measured what happened in their brains. The vaccine triggered elevated levels of IL-6 in the hippocampus, the exact cytokine that Patterson had identified as critical for mediating behavioral and transcriptional changes in offspring. As the Chinese team noted: "This work reveals for the first time that early HBV vaccination induces impairments in behavior and hippocampal neurogenesis."

But there's one more twist to this mechanism, one that explains why so many parents report their child's regression immediately after the MMR vaccine, even though MMR contains no aluminum. As Vaccine Papers explains: the MMR vaccine stimulates MCP-1 production, which causes macrophages containing aluminum from prior vaccines to mobilize and transport aluminum into the brain. "This may explain how MMR could cause Al toxicity, even though it does not contain aluminum adjuvant."

Handley describes the result: "His head always seemed to hurt. Sometimes he slaps himself in the head, he often seeks head pressure, seemingly to alleviate discomfort." The child's brain is literally swollen, inflamed, fighting an invisible war it cannot win.

3. The Epilepsy Connection

The connection between autism and epilepsy has long puzzled clinicians. Parents report the cruel progression: first the vaccines, then the autism diagnosis, then the seizures. Dr. Exley's images of aluminum-loaded hippocampal tissue provide the missing explanation—the same aluminum deposits that trigger autism's behavioral symptoms also prime the brain for electrical storms.

The hippocampus acts as the brain's electrical relay station, and as Exley notes, it is "the main region of the brain targeted in epilepsy." When aluminum deposits accumulate there, they create what Exley describes in a 15-year-old boy's brain as areas where "glial cells loaded with aluminum, likely to be microglia surround an area of aluminum-induced damage, possibly neuronal damage."

In image after image from autistic brains, Exley finds the same pattern in the hippocampus: aluminum concentrated in non-neuronal cells, particularly astrocytes and microglia. These cells, normally responsible for maintaining the brain's electrical balance, instead become sources of chronic inflammation. A 14-year-old boy with autism showed "aluminum is clearly located in some form of glial cells." A 22-year-old man displayed glial cells, "probably astrocytes loaded with aluminum."

The consistency across cases suggests not coincidence but mechanism. As Exley observes: "I am sure that you can see the similarities between aluminum in the hippocampus in epilepsy and in autism."

The aluminum acts as a permanent irritant, like a splinter the brain cannot remove. Each attempt by immune cells to clear it triggers more inflammation, more cytokine release, more disruption to normal electrical patterns. The seizures that eventually emerge represent the brain's electrical system finally overwhelming its damaged regulatory circuits.

This explains why anti-epileptic medications often fail in autistic patients—they're treating the electrical symptoms while the underlying cause, aluminum-triggered inflammation, continues unchecked. It's like replacing fuses while leaving bare wires exposed. The brain keeps short-circuiting because the fundamental insult remains.

Dr. Guillemette Crépeaux's research adds another dimension. Her team discovered that aluminum adjuvants specifically impair autophagy—the cellular recycling process. As she explains: "Our working hypothesis is then that in certain people the autophagic capacities would be less good, and when the cells of these people find themselves faced with an environmental challenge that is particularly complicated to manage (aluminum particles), they find themselves overwhelmed and are unable to eliminate them, which results in (among other things) the persistence of these particles and the inflammation they cause."

In the hippocampus, failed autophagy means accumulating cellular debris, further inflammation, and progressive dysfunction. The aluminum doesn't just trigger initial damage; it prevents the brain from healing itself.

Autism typically manifests between twelve and thirty-six months, coinciding with the most intensive period of vaccination. The temporal relationship matters, as Sally Ozonoff's 2018 study showed that up to 88% of autism cases are characterized by regression—the child was developing normally and then suddenly lost skills.

What makes the hippocampal involvement especially tragic is its role in memory formation and emotional regulation. The hippocampus doesn't just regulate seizures; it encodes new memories, processes emotions, and enables learning. When aluminum-triggered inflammation damages this region, it doesn't just risk seizures—it fundamentally alters how a child experiences and remembers their world.

The aluminum-autism-epilepsy triad represents one of medicine's most devastating iatrogenic disasters. We inject aluminum to provoke immunity, it travels to the brain, triggers autism through immune activation, damages the hippocampus, and eventually may manifest as seizures. Each step follows logically from the last, each supported by published research, each visible in the fluorescent glow of aluminum in brain tissue that should never contain it.

4. The Architecture of Suppression

The story of aluminum adjuvant research is as much about what hasn't been studied as what has. Dr. Christopher Exley's forced departure from Keele University after 29 years illuminates how scientific institutions eliminate inconvenient research. Despite publishing over 200 peer-reviewed papers and becoming the world's foremost authority on aluminum toxicity, Exley was systematically defunded, censored, and ultimately removed when his research began definitively linking aluminum adjuvants to autism.

The suppression began subtly. As Exley describes, his university failed to support and publicize his groundbreaking findings on aluminum in brain tissue in Alzheimer's disease and autism. When Exley's team discovered the highest aluminum levels ever recorded in autistic brain tissue, institutional support evaporated.

Funding disappeared next. As Exley notes in his interview: "Sadly I am no more. Without an active research group and laboratory I am not much better than an internet commentator." The scientist who discovered aluminum's causal role in autism was reduced to writing on Substack because institutions wouldn't support the research.

Toby Rogers's analysis of over 850 autism causation studies exposes the broader pattern. The CHARGE study at UC Davis produced 144 peer-reviewed publications analyzing air pollution, pesticides, heavy metals, and other environmental factors—but never controlled for vaccines. As Rogers notes: "The failure to control for vaccine exposures renders all of the CHARGE studies unreliable."

Rogers identifies the mechanism: "Everyone involved with these studies knows that if they include vaccines as a variable they would instantly lose all of their research funding and be blacklisted from future research funding. That one, principled, and scientifically necessary decision would immediately and permanently end their careers."

The same pattern appears across all major autism studies. MARBLES produced 151 peer-reviewed publications but doesn't control for vaccines. SEED generated 54 publications without examining vaccination status. EARLI created 88 publications while ignoring the variable that matters most. Each study cost millions, involved hundreds of researchers, and carefully avoided the most obvious environmental exposure.

Dr. Guillemette Crépeaux confirms this reality: "There are only two small teams in the world studying these questions, even though serious warning signs are also present regarding the vaccination of adolescents against papillomaviruses." Two teams, studying what may be the primary cause of the autism epidemic.

The suppression extends beyond research. In 2017, three of the leading scientists in the world—Christopher Shaw, Romain Gherardi, and Christopher Exley—wrote private letters to the directors of the CDC, FDA, and NIH warning about aluminum adjuvants.

Shaw wrote: "I am convinced that aluminum adjuvants in vaccines may contribute to neurological disorders across the lifespan. In children, there is growing evidence that aluminum adjuvants may disrupt developmental processes in the central nervous system and therefore contribute to ASD in susceptible children.... In regard to the above, it is my belief that the CDC's claim on its website that 'Vaccines Do Not Cause Autism' is wholly unsupported."

Gherardi stated: "I strongly support the contention that aluminum adjuvants in vaccines may have a role in the etiology of autism spectrum disorder (ASD). My view is founded on a significant and burgeoning body of peer-reviewed scientific evidence which makes the link between ASD and exposure to aluminum through vaccinations and other sources."

Exley declared: "As an expert in the field of aluminum adjuvants and aluminum toxicity I solemnly declare that more research on the role of aluminum adjuvant in vaccines and neurological disorders, including ASD, is essential and urgently required."

These weren't fringe researchers but leading scientists at major universities, yet their warnings were ignored.

The Simons Foundation exemplifies institutional capture. Despite spending over $300 million searching for autism genes, they found nothing explaining more than 1% of cases. When the Hallmayer twin study they supported showed autism is primarily environmental (at least 62% of cases), not genetic, they continued funding genetic research while ignoring environmental factors.

As Rogers documents, the genetic studies have produced hundreds of papers identifying "risk genes" that collectively explain almost nothing. The ASC identified 174 genes, MSSNG found 134 genes, SPARK discovered ten genes—all accounting for trivial percentages of autism cases while consuming billions in research funding that could have investigated aluminum adjuvants.

French researchers faced similar suppression. After Gherardi and colleagues published their Trojan horse findings, showing aluminum travels from injection sites to the brain, they found their funding cut. As they noted in a 2018 paper: "To date, aluminum adjuvants per se have, perhaps surprisingly, not been the subject of any official experimental investigation, and this being in spite of the well-established neurotoxicity of aluminum."

The safety standards themselves reveal the suppression. As Vaccine Papers explains about the FDA's Mitkus study, which declares aluminum adjuvants safe: "Mitkus 2011 is the best scientific evidence vaccine promoters have for defending Al adjuvant safety. It is fatally flawed and incredibly bad. It is not based on any toxicity experiments with actual Al adjuvant."

The entire safety assessment for injecting aluminum into infants rests on a study that used the wrong aluminum (citrate not hydroxide), the wrong method (infusion not injection), and the wrong population (adults not infants). No other drug would ever be approved with such inappropriate safety testing.

5. The Epidemiological Proof

Toby Rogers spent years mapping the entire field of autism causation research—over 850 studies—and reached a startling conclusion: when you remove the studies compromised by financial conflicts of interest or fatal design flaws, a clear pattern emerges. The vaccine schedule, particularly its aluminum-containing shots, is driving the autism epidemic.

The numbers tell the story. A fully vaccinated child in the mid-1980s received 1,250 micrograms of aluminum by eighteen months. Today, a fully vaccinated child receives 4,925 micrograms of aluminum—a near quadrupling. The correlation with autism rates is undeniable.

But correlation, the eternal deflection goes, doesn't prove causation. Which brings us to the six vaccinated versus unvaccinated studies that mainstream medicine pretends don't exist. These studies, conducted by independent researchers without pharmaceutical funding, consistently find the same result: unvaccinated children have dramatically lower rates of autism.

Gallagher and Goodman, using National Health Interview Survey data, found that boys "who received the first dose of hepatitis B vaccine during the first month of life had 3-fold greater odds for autism diagnosis" compared with "boys either vaccinated later or not at all." Using different data from the National Health and Nutrition Examination Survey, they found boys who received all three hepatitis B doses were 8.63 times more likely to have a developmental disability including autism.

Mawson's 2017 study of 666 homeschooled children found vaccinated children were significantly more likely than unvaccinated to have been diagnosed with autism (4.7% vs. 1.0%; OR = 4.2). But the subgroup analysis revealed something more disturbing. Preterm birth coupled with vaccination increased the odds of neurodevelopmental disorders by more than fourteen-fold "compared to children who were neither preterm nor vaccinated."

If Mawson's findings are correct, then the high rates of neurodevelopmental disorders among premature infants may be due almost entirely to vaccination, rather than early arrival.

Hooker and Miller's 2021 study found even more dramatic differences. Vaccinated children were 5.03 times more likely to have autism. But the combination effects were staggering: "Children who were 'vaccinated and not breastfed' had a more than 12-fold higher risk of autism" and "Children who were 'vaccinated and delivered via cesarean section' had a more than 18-fold higher risk of autism."

These are the highest odds ratios seen in any autism causation study. In a functioning public health system, these findings would trigger immediate investigation and policy changes.

Mawson and Jacob's 2025 analysis of Florida Medicaid data for 47,155 children showed a clear dose-response relationship: "Children with just one vaccination visit were 1.7 times more likely to have been diagnosed with ASD than the unvaccinated whereas those with 11 or more visits that included vaccinations were 4.4 times more likely to have been diagnosed with ASD than those with no visit for vaccination."

Among children born preterm, "39.9% were diagnosed with at least one NDD compared to 15.7% among those born preterm and unvaccinated."

These studies expose the fatal flaw in every CDC-funded study claiming no vaccine-autism link. As Rogers explains: "Mainstream studies that attempt to prove that vaccines do not cause autism are all invalid because they do not have a proper unvaccinated control group."

The twenty-two studies the CDC cites compare fully vaccinated children to slightly less vaccinated children, then declare no difference found. It's like comparing different brands of cigarettes and concluding smoking doesn't cause cancer.

Sally Ozonoff's 2018 study adds crucial insight into timing. She found that "up to 88% of autism cases are characterized by autistic regression"—normal development followed by loss of skills. This isn't a genetic condition manifesting gradually; it's an acute injury with a specific trigger.

The genetic studies themselves disprove the genetic hypothesis. The Hallmayer twin study (2011), using California birth records and sixteen leading geneticists, found that "genetic heritability explains at most 38% of ASD cases" and noted this is likely an overestimate. "So at least 62% of autism cases (and likely significantly more) are caused by something other than genes."

Despite this definitive finding, billions continue flowing into genetic research. As Rogers documents, the various genetic studies—AGRE (169 papers), SSC (132 papers), ASC (22 papers), MSSNG (138 papers), SPARK (40 papers)—have collectively identified hundreds of "risk genes" that explain less than 1% of autism cases.

Meanwhile, every animal study examining aluminum adjuvants finds harm. As Crépeaux notes: "We have recently shown that in almost each of the 31 studies which have been carried out in animals on the questions of bio-persistence, translocation or neurotoxicity of aluminum adjuvants, a significant difference is observed between the exposed groups and the control groups. In other words, every time we expose an animal (rodents, rabbits, sheep) to these compounds, something negative happens."

The epidemiological picture is complete. We have a clear environmental exposure (aluminum adjuvants), a documented mechanism (immune activation via macrophage transport), a susceptible population (infants with immature blood-brain barriers), a temporal relationship (regression following vaccination), a dose-response curve (more vaccines equal more autism), and a control group (the unvaccinated with minimal autism).

6. The Reckoning

The evidence is now comprehensive and undeniable. As Dr. Exley states after forty years of research: "Aluminum has a causal role in the instigation and subsequent development of autism. This is the conclusion I am expecting in the imminent announcement from Health and Human Services."

The mechanism is understood at every level. Handley summarizes the eleven discoveries: "We now know that autism is created by immune activation events in the brain during critical phases of brain development, typically by the time a child is thirty-six months old, and that these immune activation events in the brain can be triggered by the aluminum adjuvant in vaccines."

The aluminum travels to the brain via what the French scientists call the "Trojan horse mechanism"—macrophages carrying aluminum they cannot digest. Once there, it triggers the permanent immune activation that Dr. Patterson identified in autistic brains. The IL-6 elevation disrupts synapse formation during critical developmental windows. The result is what we call autism but what is more accurately termed vaccine-induced encephalitis.

Three of the world's leading aluminum researchers felt compelled to warn health authorities directly. Their letters to the CDC, FDA, and NIH represent extraordinary acts of scientific courage, knowing the career consequences of challenging vaccine orthodoxy.

Dr. Patterson himself, before his death in 2014, warned about the implications of his own research: "Should we really be promoting universal maternal vaccination? ... Remember that double-stranded RNA experiment—we activated the immune system, and it caused all these downstream effects on the fetus. And what does a vaccination do? It activates the immune system. That's the point of vaccination."

His widow Carolyn revealed that Patterson's own nephew regressed after vaccines, and that his colleagues "were favorable about your conclusions" regarding the vaccine-autism connection but "none of them would go against the vaccination theory, per se" because they fear being "Wakefielded."

The solutions are straightforward. As Exley prescribes: "We need to think carefully, is this vaccine a life-saving vaccine or not? If it isn't, don't have it with an aluminum adjuvant."

For those already injured, some hope exists. Exley discovered that silicon-rich mineral water facilitates aluminum excretion. In a clinical trial with Alzheimer's patients, "over just 12 weeks 20% of the participants registered clinically significant improvements in their cognitive performance. This level of success has never been achieved in any mainstream clinical trial on Alzheimer's disease."

Dennis Crouse, a PhD chemist who has spent years studying aluminum's role in neurological disease after his mother's Alzheimer's diagnosis, offers additional hope through what he calls the "Crouse Protocol." Beyond silicon-rich water (which he terms "Silicade"), Crouse has identified specific nutrients that facilitate aluminum detoxification: vitamin D, which lowers serum and tissue aluminum levels; selenium for mercury detoxification and immune support; B vitamins for lead and PCB detoxification; and zinc for additional lead removal. His protocol also addresses the mitochondrial damage aluminum causes through PQQ and CoQ10 supplementation.

Crouse's work confirms what Exley discovered—that orthosilicic acid (OSA) in silicon-rich water crosses the blood-brain barrier and facilitates aluminum elimination from all analyzed brain regions. He documented his mother's improvement on the Mini Mental State Exam after a year of drinking OSA-rich water, with her sundowners eliminated and memory consolidation restored, allowing her to live to 97 without reaching end-stage Alzheimer's.

Most critically, Crouse emphasizes prevention through aluminum avoidance. As his wife Laurie Adamson, a psychologist who witnessed autism rates soar in schools, explains: mothers should drink OSA-rich water during pregnancy, and children should drink it from birth to counteract aluminum from soy formula and vaccines. Parents in online groups report dramatic improvements, including complete elimination of seizures in some autistic children after OSA treatment—unsurprising given that aluminum directly causes seizures in primate studies.

The broader implications are staggering. As Rogers calculates: "We can stop the autism epidemic by only allowing beneficial vaccines on the market (a couple of live virus vaccines) and giving them, if at all, under conditions of informed consent at later ages when the body's immune system can respond appropriately."

The French scientists who discovered the Trojan horse mechanism concluded their paper with words that should haunt every health official: "In the context of massive development of vaccine-based strategies worldwide, the present study may suggest that aluminum adjuvant toxicokinetics and safety require reevaluation."

"Require reevaluation" is scientific understatement. What's required is the immediate removal of aluminum adjuvants from all vaccines, especially those given to infants. Every day of delay, more children develop what Exley calls "autism spectrum disorders, considered to be the consequence of early inflammation and autophagy disorders."

The CDC continues to claim on its website that "Vaccines Do Not Cause Autism," a statement that Dr. Shaw, based on the scientific evidence, calls "wholly unsupported." The agency tasked with protecting public health instead protects the vaccine program, regardless of the human cost.

We stand at a crossroads. The science is complete. The mechanism is proven. The solution is obvious. All that remains is the courage to act on what we know. As Exley writes with palpable frustration about the expected announcement that aluminum causes autism: "This means a moratorium on the use of aluminum adjuvanted vaccines should follow and the instigation of a major NIH funding programme on human exposure to aluminum. My breath is baited!"

The science shows that autism is not a genetic mystery or an unexplained epidemic. It is vaccine-induced encephalitis, caused by aluminum adjuvants that transport to the brain and trigger permanent immune activation. Every piece of evidence—from the fluorescent images of aluminum in autistic brains to the epidemiological studies showing dose-response relationships to the animal studies showing universal harm—points to the same conclusion.

The age of injecting neurotoxic aluminum into infants will end. The only question is how many more children will be sacrificed before it does. As one researcher noted about the implications: "In time, it may well be shown that aluminum is a cause of this environmental disease."

That time has arrived. The evidence is in. Aluminum adjuvants cause autism. The epidemic is iatrogenic, caused by the medical system itself. And it will continue until we find the courage to stop injecting aluminum into babies, to stop pretending we don't know what we clearly know, to stop sacrificing children to preserve institutional reputations.

Rogers provides the stark conclusion: "We know what's causing the autism epidemic. The bloated, unscientific, profit-driven CDC vaccine schedules are causing the autism epidemic."

The reckoning is not coming. It is here.

References

Dr. Christopher Exley's Substack Articles

Exley C. Aluminium, Autism and Epilepsy. Dr's Newsletter. Substack. August 18, 2025.

Exley C. Aluminium and Autism: Unequivocal. Dr's Newsletter. Substack. August 11, 2025.

Exley C. Aluminium and Autism: The Evidence. Dr's Newsletter. Substack. July 24, 2025.

Interview Articles

Unbekoming. Interview with Dr Christopher Exley: On Aluminium, Adjuvants, Alzheimer's, Fluoride and more. Lies are Unbekoming. Substack. April 6, 2024.

Unbekoming. Imagine you are an Aluminum Atom: By Dr Christopher Exley – Unbekoming Book Summary. Lies are Unbekoming. Substack. July 2, 2024.

Unbekoming. Interview with Guillemette Crépeaux: On Aluminum, Adjuvants, Autophagy, Chronic Fatigue Syndrome, Autism and more. Lies are Unbekoming. Substack. March 23, 2024.

Unbekoming. Interview with Dennis N Crouse PhD: On Aluminium, Beta Amyloids, The Crouse Protocol, Alzheimer's, Silicade and much more. Lies are Unbekoming. Substack. September 4, 2024.

Analysis Articles

Rogers T. Mapping the entire field of autism causation studies in one article. uTobian. Substack. May 22, 2025.

Unbekoming. Real Autism Science: With thanks to J.B. Handley. Lies are Unbekoming. Substack. October 21, 2022.

I appreciate you being here.

If you've found the content interesting, useful and maybe even helpful, please consider supporting it through a small paid subscription. While 99% of everything here is free, your paid subscription is important as it helps in covering some of the operational costs and supports the continuation of this independent research and journalism work. It also helps keep it free for those that cannot afford to pay.

Please make full use of the Free Libraries.

Unbekoming Interview Library: Great interviews across a spectrum of important topics.

Unbekoming Book Summary Library: Concise summaries of important books.

Stories

I'm always in search of good stories, people with valuable expertise and helpful books. Please don't hesitate to get in touch at unbekoming@outlook.com

Baseline Human Health

Watch and share this profound 21-minute video to understand and appreciate what health looks like without vaccination.